Reuters: Abbott stent superior to Boston Sci after 3 years: study

[NaDiNe]

Abbott stent superior to Boston Sci after 3 years: study
      
   
      

NEW YORK (Reuters) - Safety advantages of Abbott Laboratories' Xience stent over Boston Scientific Corp's rival Taxus stent increased between two and three years, according to long-term data presented on Sunday.<div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login